Search Results

Overview

Uniprot IDP06312
Protein NameImmunoglobulin kappa variable 4-1
Gene NameIGKV4-1
OrganismHomo sapiens

Kla Sites from experimental identification

Position Flanking peptide
65 YLAWYQQKPGQPPKL

Function

V segment of the variable domain of immunoglobulins light chain that participates in the antigen recognition (PubMed:24600447). Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268)

Protein Sequence

10 MVLQTQVFIS 20 LLLWISGAYG 30 DIVMTQSPDS 40 LAVSLGERAT 50 INCKSSQSVL 60 YSSNNKNYLA 70 WYQQKPGQPP 80 KLLIYWASTR 90 ESGVPDRFSG 100 SGSGTDFTLT 110 ISSLQAEDVA 120 VYYCQQYYST P

Gene Ontology

Classification GO ID Description
Cellular Component GO:0072562 blood microparticle
Cellular Component GO:0005576 extracellular region
Cellular Component GO:0019814 immunoglobulin complex
Cellular Component GO:0005886 plasma membrane
Molecular Function GO:0003823 antigen binding
Biological Process GO:0002250 adaptive immune response
Biological Process GO:0006955 immune response

Reference

[1] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.